ClinicalTrials.gg
Drug

Simendan clinical trials

Also written Simdax and ODM-109.

studies test it
75
open now
5
in phase 3
24
first study started
2002

How each study uses Simendan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Simendan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Levosimendan
69
Levosimendan 2.5 mg/mL Injectable Solution
2

Brand

Simdax
20

Development codes

ODM-109
3

Studies by the year they started

75 studies that test it; most in 2009 (7)

Studies that test Simendan, by start year
YearStudies
20022
20031
20042
20054
20062
20072
20082
20097
20103
20116
20123
20132
20144
20153
20161
20172
20186
20195
20205
20215
20221
20235
20252

Who runs them

Industry 13 · Other 62

Orion Corporation, Orion Pharma (7) · Assistance Publique - Hôpitaux de Paris (4) · Tenax Therapeutics, Inc. (3) · Sahlgrenska University Hospital (3) · Ain Shams University (2) · Göteborg University (2) · Tampere University Hospital (2) · University Medical Center Nijmegen (2)

Often tested with

Tested in the same studies.

Dobutamine (5) · Milrinone (4) · Magnesium Sulfate (1) · Epinephrine (1) · Norepinephrine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Simendan, phase 3 first.

Studies

Open first, then newest update. How each study uses Simendan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test Simendan →

As the comparator · 2 — what is tested is compared with Simendan

Codes

What other systems call Simendan · ClinicalTrials.gg INT006729

  • MeSH (NLM) D000077464SimendanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 349552KRHKSIMENDANConfirmed FDA, NLM, Wikidata
  • Wikidata Q27256351simendanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87689SimendanOne source FDA
  • DrugBank DB12286One source Wikidata

Also registered as levosimendan (UNII C6T4514L4E · RxNorm 73107).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.